🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Clinical efficacy and tolerability for allergen specific immunotherapy (AIT...
Status
Completed
Location
Karolinska University Hospital
Start Date
2023-02-01
Trial ID
NCT06085963
Treatments Being Tested
The goal of this clinical trial is to compare full dose MDMA-assisted thera...
Status
Terminated
Location
Offices of Dr. Ingrid Pacey MBBS FRCP[C]
Start Date
2014-10-14
Trial ID
NCT01958593
Treatments Being Tested
The primary purpose of the study is to test the efficacy of 2 tablets (twic...
Status
Completed
Location
Site Reference ID/Investigator# 10044
Start Date
2008-09
Trial ID
NCT00763321
This randomized dose-ranging study will evaluate the safety, tolerability, ...
Status
Unknown
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01520116
People with asthma suffer from breathlessness because the small tubes (bron...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-07-20
Trial ID
NCT01400906
Treatments Being Tested
The aim of the current study is to examine the role of the opioïd system on...
Status
Completed
Location
CIC Neurologie GHPS
Start Date
2013-10-30
Trial ID
NCT02267304
Treatments Being Tested
This will be a single-center, randomized, parallel group, multiple dose adm...
Status
Completed
Location
Mayo Clinic
Start Date
2012-03
Trial ID
NCT01523184
The purpose of this study is to evaluate the safety, efficacy, and tolerabi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT00741884
The main objective of the trial is to document the efficacy of NGR-hTNF adm...
Status
Completed
Location
Zentralklinik Bad Berka GmbH
Start Date
2011-03
Trial ID
NCT01358084
Treatments Being Tested
Background and purposes:Chloroquine (CLQ), an antimalarial drug, has a lyso...
Status
Terminated
Location
Instituto Nacional de Cancerologia
Start Date
2011-05
Trial ID
NCT01894633
Treatments Being Tested